ritipenem has been researched along with imipenem, anhydrous in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (70.59) | 18.7374 |
| 1990's | 5 (29.41) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altamura, M; Arcamone, F; Cascio, G; Lorenzi, L; Morandotti, G; Perrotta, E; Pestellini, V; Satta, G; Sbraci, P; Sperning, R | 1 |
| Ellis, ME; Qadri, SM; Ueno, Y | 1 |
| Livermore, DM; Wu, PJ; Yang, YJ | 1 |
| Burman, LA; Cassinelli, G; Corigli, R; Dornbusch, K; Franceschi, G; Norrby, SR; Sassella, D | 1 |
| Dworkin, RJ; Kennedy, SL; Sachdeva, M; Sande, MA; Tureen, JH | 1 |
| Lahnborg, G; Nord, CE | 1 |
| Barry, AL; Jones, RN; Thornsberry, C | 1 |
| Piddock, LJ; Traynor, EA; Wise, R | 1 |
| Asad, S; Maskell, JP; Tang, T; Williams, JD | 1 |
| Dornbusch, K; Göransson, E; Kronvall, G; Mörtsell, E | 1 |
| Chin, NX; Labthavikul, P; Neu, HC | 1 |
| Aldridge, KE; Allen, SD; Barry, AL; Fuchs, PC; Gerlach, EH; Jones, RN; Pfaller, MA | 1 |
| Bywater, MJ; Holt, HA; Reeves, DS | 1 |
| Broholm, KA; Liljedahl, AL; Norrby, SR; Schliamser, SE | 1 |
| Schliamser, SE | 1 |
| Ernst, F; Glupczynski, Y; Grenier, P; Husson, M; Klastersky, J; Van der Auwera, P | 1 |
| Akama, M; Araki, H; Iyobe, S; Minami, S; Mitsuhashi, S; Narita, H; Watanabe, Y | 1 |
1 trial(s) available for ritipenem and imipenem, anhydrous
| Article | Year |
|---|---|
Pharmacokinetics in healthy subjects of FCE 22101 and its acetoxymethyl ester, FCE 22891: effect of co-administration of imipenem/cilastatin on the renal metabolism of FCE 22101.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Chromatography, High Pressure Liquid; Cilastatin; Cilastatin, Imipenem Drug Combination; Dipeptidases; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Humans; Imipenem; Kidney; Lactams; Male; Reference Values | 1990 |
16 other study(ies) available for ritipenem and imipenem, anhydrous
| Article | Year |
|---|---|
2-Substituted penems with amino acid-related side chains: synthesis and antibacterial activity of a new series of beta-lactam antibiotics.
Topics: Amino Acids; Anti-Bacterial Agents; Bacteria; beta-Lactams; Enterococcus faecalis; Escherichia coli; Hydroxyproline; Molecular Conformation; Molecular Structure; Penicillins; Proline; Pseudomonas aeruginosa; Staphylococcus aureus; Structure-Activity Relationship | 1995 |
Antibacterial activity of FCE 22101 against relatively resistant blood culture isolates.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Microbial; Enterobacteriaceae; Humans; Imipenem; Methicillin Resistance; Saudi Arabia; Staphylococcus aureus | 1991 |
Biochemical characterization of a beta-lactamase that hydrolyzes penems and carbapenems from two Serratia marcescens isolates.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Hydrolysis; Imipenem; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Serratia marcescens; Spectrophotometry, Ultraviolet | 1990 |
Evaluation of FCE 22101 in experimental meningitis caused by Escherichia coli and Streptococcus pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Blood Bactericidal Activity; Carbapenems; Ceftriaxone; Escherichia coli Infections; Imipenem; Meningitis; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillins; Rabbits | 1989 |
Efficacy of FCE 22101 compared with imipenem and with gentamicin plus metronidazole in the treatment of experimental intra-abdominal infections in rats.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Gentamicins; Imipenem; Male; Metronidazole; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains; Time Factors | 1989 |
In-vitro activity of the penem, FCE 22101, and tentative interpretive criteria for disc susceptibility tests.
Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Drug Resistance, Microbial; Imipenem; Microbial Sensitivity Tests | 1989 |
Activity of FCE 22101 against methicillin-resistant Staphylococcus aureus and affinity for penicillin binding proteins.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Carrier Proteins; Hexosyltransferases; Imipenem; Methicillin; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin Resistance; Penicillin-Binding Proteins; Peptidyl Transferases; Staphylococcus aureus | 1989 |
Comparative inhibitory and bactericidal activities of FCE 22101 against gram-positive cocci and anaerobes in vitro.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Carbapenems; Clostridium; Culture Media; Gram-Positive Bacteria; Imipenem; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus | 1989 |
In-vitro activity of FCE 22101 against respiratory tract pathogens with reference to production of beta-lactamases.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Carbapenems; Ceftibuten; Cephalosporins; Imipenem; Microbial Sensitivity Tests; Respiratory Tract Infections | 1989 |
The in-vitro activity of a novel penem FCE 22101 compared to other beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Gram-Negative Bacteria; Imipenem; Microbial Sensitivity Tests; Penicillanic Acid; Thienamycins | 1985 |
In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101.
Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Ceftazidime; Imipenem; Microbial Sensitivity Tests; Quality Control | 1988 |
Activity of penems against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Microbial; Imipenem; Lactams; Methicillin; Microbial Sensitivity Tests; Staphylococcus aureus | 1988 |
Comparative neurotoxicity of benzylpenicillin, imipenem/cilastatin and FCE 22101, a new injectible penem.
Topics: Animals; Anti-Bacterial Agents; Brain; Carbapenems; Cilastatin; Drug Interactions; Electroencephalography; Imipenem; Penicillin G; Rabbits | 1988 |
Neurotoxicity of beta-lactam antibiotics. Experimental kinetic and neurophysiological studies.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Blood-Brain Barrier; Brain; Carbapenems; Cilastatin; Drug Interactions; Electroencephalography; Enterobacteriaceae Infections; Female; Hippocampus; Imipenem; Male; Meningitis; Penicillin G; Rabbits; Rats; Rats, Inbred Strains; Seizures; Thiopental; Tissue Distribution; Uremia | 1988 |
In-vitro activity of two new carbapenems FCE 22101 and CGP 31608 in comparison with imipenem.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Synergism; Hydrogen-Ion Concentration; Imipenem; Lactams; Microbial Sensitivity Tests; Thienamycins | 1987 |
Imipenem and cephem resistant Pseudomonas aeruginosa carrying plasmids coding for class B beta-lactamase.
Topics: Anti-Infective Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporinase; Hydrolysis; Imipenem; Isoelectric Focusing; Microbial Sensitivity Tests; Ofloxacin; Plasmids; Porins; Pseudomonas aeruginosa; Thienamycins | 1996 |